Johannes Gutenberg-Universität Mainz
- 6131/39-0
Münch, N
Resilienz und Partizipation in der PflegeTina Drechsel, Julia Inthorn (Hrsg). Wie viel Technik ist menschlich? Medienpädagogische und ethische Auseinandersetzung mit Digitalisierung in der Pflegeausbildung. 1. Aufl. München: kopaed 2020
Siemer, Svenja; Westmeier, Dana; Vallet, Cecillia et al.
Resistance to Nano-Based Antifungals Is Mediated by Biomolecule Coronas (Retraction of Vol 12, Pg 15953, 2020)ACS APPLIED MATERIALS & INTERFACES. Bd. 12. H. 13. 2020 S. 15953-15953
Dietz, Julia; Kalinina, ?; Vermehren, Johannes et al.
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infectionJOURNAL OF VIRAL HEPATITIS. 2020
Nogueira, Andressa V. B.; Nokhbehsaim, Marjan; Tekin, Sema et al.
Resistin Is Increased in Periodontal Cells and Tissues: In Vitro and In Vivo StudiesMEDIATORS OF INFLAMMATION. Bd. 2020. 2020
Virchow, J. Christian; McDonald, Mirna; Garin, Margaret et al.
Reslizumab as add-on therapy in patients with refractory asthmaBMJ OPEN RESPIRATORY RESEARCH. Bd. 7. H. 1. 2020
Uphaus, Timo; Bittner, Stefan; Groeschel, Klaus
Response by Uphaus et al to Letter Regarding Article, "NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke"STROKE. Bd. 51. H. 2. 2020 S. E31-E31
Stege, H.; Haist, M.; Mohr, P. et al.
Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma - a retrospective multicenter retrospective studyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 18. 2020 S. 12-13
Pavord, Ian D.; Bleecker, Eugene R.; Buhl, Roland et al.
Response to mepolizumab treatment is sustained across 4-weekly dosing periodsERJ OPEN RESEARCH. Bd. 6. H. 3. 2020
Alwers, Elizabeth; Jansen, Lina; Kather, Jakob et al.
Response to neoadjuvant treatment among rectal cancer patients in a population-based cohortINTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 2020
Goldschmidt, Hartmut; Mai, Elias K.; Duerig, Jan et al.
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trialLEUKEMIA. 2020